These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18691642)

  • 21. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for measuring ligand dissociation and nuclear receptor turnover in whole cells.
    Wilson EM
    Methods Mol Biol; 2009; 505():21-33. PubMed ID: 19117137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors.
    Bursztyka J; Perdu E; Pettersson K; Pongratz I; Fernández-Cabrera M; Olea N; Debrauwer L; Zalko D; Cravedi JP
    Toxicol In Vitro; 2008 Sep; 22(6):1595-604. PubMed ID: 18640261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary hazard evaluation of androgen receptor-mediated endocrine-disrupting effects of thioxanthone metabolites through structure-based molecular docking.
    Ginex T; Dall'Asta C; Cozzini P
    Chem Res Toxicol; 2014 Feb; 27(2):279-89. PubMed ID: 24387784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleiotropic functional properties of androgen receptor mutants in prostate cancer.
    Bergerat JP; Céraline J
    Hum Mutat; 2009 Feb; 30(2):145-57. PubMed ID: 18800375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of androgen and estrogen receptor expression by antiepileptic drugs and steroids in hippocampus of patients with temporal lobe epilepsy.
    Killer N; Hock M; Gehlhaus M; Capetian P; Knoth R; Pantazis G; Volk B; Meyer RP
    Epilepsia; 2009 Aug; 50(8):1875-90. PubMed ID: 19490052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro profiling of the endocrine disrupting potency of organochlorine pesticides.
    Li J; Li N; Ma M; Giesy JP; Wang Z
    Toxicol Lett; 2008 Dec; 183(1-3):65-71. PubMed ID: 18992306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible involvement of androgen receptor alterations in hepatocarcinogenesis.
    Barone M; Margiotta M; Scavo MP; Gentile A; Francioso D; Papagni S; Castellaneta A; Mallamaci R; Di Leo A; Francavilla A
    Dig Liver Dis; 2009 Sep; 41(9):665-70. PubMed ID: 19201267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel method for evaluation of chemicals based on ligand-dependent recruitment of GFP labeled coactivator to estrogen receptor displayed on bacterial magnetic particles.
    Yoshino T; Kaji C; Nakai M; Saito F; Takeyama H; Matsunaga T
    Anal Chim Acta; 2008 Sep; 626(1):71-7. PubMed ID: 18761123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor knockout and knock-in mouse models.
    Kerkhofs S; Denayer S; Haelens A; Claessens F
    J Mol Endocrinol; 2009 Jan; 42(1):11-7. PubMed ID: 18923000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor-DNA interactions: EMSA and footprinting.
    Read JT; Cheng H; Hendy SC; Nelson CC; Rennie PS
    Methods Mol Biol; 2009; 505():97-122. PubMed ID: 19117141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders.
    Swedenborg E; Rüegg J; Mäkelä S; Pongratz I
    J Mol Endocrinol; 2009 Jul; 43(1):1-10. PubMed ID: 19211731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-androgen activity of polybrominated diphenyl ethers determined by comparative molecular similarity indices and molecular docking.
    Yang W; Mu Y; Giesy JP; Zhang A; Yu H
    Chemosphere; 2009 May; 75(9):1159-64. PubMed ID: 19324393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yeast-based reporter assays for the functional characterization of cochaperone interactions with steroid hormone receptors.
    Balsiger HA; Cox MB
    Methods Mol Biol; 2009; 505():141-56. PubMed ID: 19117143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding.
    Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    Fertil Steril; 2009 Mar; 91(3):933.e23-8. PubMed ID: 19062009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A bioisosteric approach to the discovery of indole carbinol androgen receptor ligands.
    Lanter JC; Fiordeliso JJ; Allan GF; Musto A; Hahn do W; Sui Z
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5646-9. PubMed ID: 16942875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homology-modeled ligand-binding domains of medaka estrogen receptors and androgen receptors: a model system for the study of reproduction.
    Cui J; Shen X; Yan Z; Zhao H; Nagahama Y
    Biochem Biophys Res Commun; 2009 Feb; 380(1):115-21. PubMed ID: 19167350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.